11.12.2017 • News

BYK Expands Texas Additives Plant

(c) twitter.com/PressBYK/media
(c) twitter.com/PressBYK/media

US additives and instruments supplier BYK, which is part of German specialty chemicals group Altana, will invest $50 million to expand its facility in Gonzales, Texas.

BYK is to increase capacities and capabilities for key products in its portfolio, specifically Garamite, which is a range of natural rheology additives. The company explained that Garamite additives have a thickening effect and can replace alternative solutions, for example, in coatings where they can contribute to the lightweight construction of cars, a key trend in the automotive industry where manufacturers are working to cut carbon emissions.

The project includes several upgrades to the site’s infrastructure as well as a new R&D facility to house a global competence center for natural rheology.

BYK is also investing in China, where it broke ground in July on a new facility in the Shanghai Chemical Industry Park. The Connecticut-based company is spending more than $30 million on the complex, which will combine R&D, technical service, logistics and administrative functions under one roof, while also forming the basis for a continued expansion in Greater China and the whole Asia-Pacific region.

The facility is scheduled to go into operation in the second half of 2018.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

most read